Company intelligence / Profile preview

Humax Pharmaceutical

La Estrella, Antioquia, Colombiaglobal.humaxdigital.com ↗

Ownership: Private
Employees: ~174
Development stage: Other

Overview

Humax Pharmaceutical is an established Colombian pharmaceutical manufacturer with over two decades of experience. It began by developing affordable antiretroviral drugs for HIV/AIDS and has since expanded its portfolio to include cardiovascular medicines, neurology products, vitamins/supplements, and other pharmaceuticals. Since its acquisition by Bausch Health in 2015, the company has strengthened quality standards and increased its presence across Latin America.

Therapeutic areas: OtherCardiovascularInfectious DiseasesNeurology
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

2 assets

zinc sulfate

Approved

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Humax Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humax Pharmaceutical.

Explore the full profile